TrialDiabetes, obesity & metabolism2017

Duration of action of two insulin glargine products, LY2963016 insulin glargine and Lantus insulin glargine, in subjects with type 1 diabetes mellitus.

Helle Linnebjerg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.